Skip to content

SRI INTERNATIONAL, INC. v. CISCO SYSTEMS, INC.

Before LOURIE, O’MALLEY, and STOLL. Appeals from the United States District Court for the District of Delaware.

Summary: Applying the proper test for willful infringement, the Federal Circuit reinstated a jury’s willfulness verdict and affirmed the district court’s damages enhancement and attorney-fee award.

IN RE: JUNIPER NETWORKS, INC.
Before LOURIE, BRYSON, and TARANTO. Per Curiam. On Petition for Writ of Mandamus to the United States District Court for the Western District of Texas.
Summary: A party’s relatively insignificant presence in a forum is an insufficient reason to deny transfer when the majority of witnesses and relevant evidence are in the desired venue.

Boston Scientific Corp. has agreed to acquire Devoro Medical Inc. in a deal expected to close this year. Boston Scientific previously held a 16% equity stake in Devoro Medical and now agrees to acquire the remaining 84% stake for $269M. Boston Scientific also agrees to pay up to $67M more if Devoro Medical clears certain regulatory and clinical milestones.

OMEGA PATENTS, LLC v. CALAMP CORPORATION

Before Prost, Dyk, and Hughes. Appeal from the United States District Court for the Middle District of Florida.

Summary: Licensing policies that allow use of any or all of a bundle of patents for a single per-unit fee are not a proper basis for establishing royalties without apportionment.

Baxter International Inc. (“Baxter”) has agreed to acquire Hillrom for $10.5 billion ($156 per share) in a deal expected to close in 2022. After assumption of debt, the total enterprise value of the deal is approximately $12.4 billion. The deal had been rumored for about a month before it was announced.

The orthopedic industry traditionally sees significant levels of intellectual property litigation activity, and this year has been no different. One source of this activity comes from Conformis who has continued to assert patents directed towards surgical planning and patient specific instruments and implants. In 2021, Conformis filed three new complaints, settled one case, and continued another litigation. These cases have involved various companies, including DePuy Synthes, Exactech, Bodycad, Wright Medical, and Medacta.

PIANO FACTORY GROUP, INC. v. SCHIEDMAYER CELESTA GMBH

Before Prost, Bryson, and Stoll. Appeal from the Trademark Trial and Appeal Board.

Summary: The appointments of TTAB judges do not share the constitutional defect that the Supreme Court remedied for PTAB judges in Arthrex.

BELCHER PHARMACEUTICALS v. HOSPIRA, INC.

Before Reyna, Taranto, and Stoll. Appeal from the District of Delaware.

Summary: A patentee committed inequitable conduct by advancing an argument during patent prosecution that contradicted the patentee’s prior arguments and evidence submitted to the FDA.

LUBBY HOLDINGS LLC v. CHUNG

Before Dyk, Newman, and Wallach. Appeal from the Central District of California.

Summary: Specific charges of infringement by a specific accused product are required to provide actual notice under 35 U.S.C. § 287 and thereby support an award of pre-suit damages.

Can certain specific medical device details remain company know-how or protected trade secrets even if patents are pursued on the medical device? Consider the Seventh Circuit’s commentary in its August 9, 2021 decision upholding a preliminary injunction in the Life Spine, Inc. v. Aegis Spine, Inc. case. The preliminary injunction prohibits Aegis from selling or marketing its competing AccelFix product (shown below, right) until the case is resolved on the merits.

Older posts
- Newer posts